Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$15.90 – $19.00
79% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.18T | $3.25T | $3.21T | $3.29T | $3.36T | $3.56T | $3.67T | $3.84T |
| Cost of revenue | $2.95T | $3.02T | $3.00T | $3.07T | $3.14T | $3.31T | $3.42T | $3.59T |
| Gross profit | $232.50B | $236.74B | $214.26B | $217.44B | $224.31B | $246.66B | $255.76B | $248.97B |
| Gross margin | 7.3% | 7.3% | 6.7% | 6.6% | 6.7% | 6.9% | 7.0% | 6.5% |
| R&D | $0 | $118.0M | $106.0M | $108.0M | $103.0M | $0 | $0 | $0 |
| Operating income | $49.83B | $53.11B | $38.58B | $45.62B | $48.97B | $47.33B | $55.61B | $53.52B |
| EBITDA | $77.57B | $90.36B | $53.37B | $59.96B | $63.62B | $65.31B | $95.16B | $81.89B |
| Net income | $34.36B | $37.97B | $23.93B | $29.42B | $38.81B | $41.47B | $40.28B | $42.80B |
| Net margin | 1.1% | 1.2% | 0.7% | 0.9% | 1.2% | 1.2% | 1.1% | 1.1% |
| EPS (diluted) | 145.15 | 165.33 | 106.80 | 131.41 | 179.12 | 195.83 | 193.20 | 207.71 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $3.93T | $1.19 | $1.17–$1.20 | 1 |
| 2028 | $4.02T | $1.24 | $1.23–$1.25 | 1 |
| 2029 | $4.07T | $1.20 | $1.18–$1.21 | 1 |
| 2030 | $4.27T | $1.43 | $1.41–$1.44 | 1 |
Forward consensus · source: Financial Modeling Prep
MEDIPAL HOLDINGS CRP ORD
No one on the platform currently holds MEPDF.
No tracked institution reports a position in MEPDF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2027-03-31 | $34.0000 | |
| 2026-09-30 | $34.0000 | |
| 2026-03-31 | $34.0000 | 2026-06-02 |
| 2025-09-30 | $32.0000 | 2025-12-02 |
| 2025-03-31 | $32.0000 | 2025-06-03 |
| 2024-09-30 | $30.0000 | 2024-12-03 |
| 2024-03-28 | $30.0000 | 2024-06-04 |
| 2023-09-29 | $30.0000 | 2023-12-04 |
No one on the platform has traded MEPDF yet.
| +0.00% |
| $3.8B |
| — |
| RGEDFGedeon Richter PLC | $38.65 | -2.37% | $7.1B | — |
| SDGCFSundrug Co.,Ltd. | $28.18 | +0.00% | $3.3B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.1× earnings vs its 0.1× historical median P/E.
Fair value ≈ $16.56 · price $18.35 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.